Teresa L. Kline - 03 Jun 2021 Form 4 Insider Report for Intersect ENT, Inc.

Role
Director
Signature
/s/ Teresa L. Kline
Issuer symbol
N/A
Transactions as of
03 Jun 2021
Net transactions value
$0
Form type
4
Filing time
07 Jun 2021, 20:41:19 UTC
Previous filing
12 May 2021
Next filing
10 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XENT Common Stock Award $0 +3,239 +37% $0.000000 12,076 03 Jun 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XENT Stock Option (right to buy) Award $0 +5,734 $0.000000 5,734 03 Jun 2021 Common Stock 5,734 $16.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest one year from grant date on June 3, 2022.
F2 Includes 3,239 restricted stock units.
F3 The shares subject to the option vest in 12 equal monthly installments commencing on June 3, 2021.